Clinical trial
A Multicentre, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the Vivasure PerQseal® Closure Device System When Used to Achieve Haemostasis of Common Femoral Arteriotomies Created by 12 to 22 F Sheaths in Patients Undergoing Percutaneous Catheter-Based Interventional Procedures
NCT05653336 is registered in ClinicalTrials.gov with Vivasure Medical Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the Vivasure PerQseal® Closure Device System When Used to Achieve Haemostasis of Common Femoral Arteriotomies Created by 12 to 22 F Sheaths in Patients Undergoing Percutaneous Catheter-Based Interventional Procedures
- Lead sponsor
- Vivasure Medical Limited
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 30, 2023
- Completion date
- June 30, 2025
- Enrollment
- 149 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
percutaneous large hole vascular closure